|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Amortization of acquisition-related intangible assets | |||||
| Total operating expenses | |||||
| Other income (expense) | |||||
| Operating income (loss) | |||||
| Financial income (expense): | |||||
| Extinguishment of debt | |||||
| Other financial income (expense) | |||||
| Income (loss) before income taxes | |||||
| Benefit (provision) for income taxes | |||||
| Results relating to equity-accounted investees | |||||
| Net income (loss) | |||||
| Less: Net income (loss) attributable to non-controlling interests | |||||
| Net income (loss) attributable to stockholders | |||||
| Earnings per share data: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average number of shares of common stock outstanding during the year (in thousands): | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...